Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Expert Opin Pharmacother. 2020 Jan 20;21(4):389–397. doi: 10.1080/14656566.2020.1713096
Drug name Odefsey
Phase Approved
Indication Preventing HIV-1 replication
Pharmacology description 2NRTIs (FTC, TAF) +NNRTI (RPV)
Route of administration Oral
Chemical structure graphic file with name nihms-1557455-t0004.jpg graphic file with name nihms-1557455-t0005.jpg graphic file with name nihms-1557455-t0006.jpg
Pivotal trial(s)  GS-US-366-1216, GS-IS-366-1160 [52][13]